Yager Joel, Gaudiani Jennifer L, Treem Jonathan
Department of Psychiatry, University of Colorado School of Medicine, Aurora, CO, USA.
Gaudiani Clinic, Denver, CO, USA.
J Eat Disord. 2022 Sep 6;10(1):135. doi: 10.1186/s40337-022-00659-x.
Premature deaths are estimated to occur in 5-20% of patients with anorexia nervosa (AN). Among them, some patients with severe and enduring anorexia nervosa (SE-AN) will die due to the medical complications of malnutrition or to suicide. Almost no literature provides guidance to patients, clinicians, and loved ones regarding clinical characteristics of those with SE-AN who recognize and accept the fact that they will not be able to survive their disease. Consistent with general medical literature on terminal illness and based on the authors' work with patients at this phase of life, we previously described four clinical characteristics of the small group of SE-AN patients who may be considered to have a terminal eating disorder. Following publication of this article, several opinions objecting to these formulations were published. The goals of this article are to respond to the key themes of concern posed by these objections, to extend our discussion of the palliative care and associated needs of these patients and their families, and to suggest ways in which the eating disorder and palliative care fields might develop more definitive criteria and consensus guidelines for the assessment and management of these patients.
Based on a selective narrative review of the literature, our combined experiences with these patients, and clinical reasoning, we address critiques grouped around five major themes: that (1) labels such as terminal AN are dangerous; (2) since AN is a treatable disorder, no SE-AN patients should be considered terminal; (3) a terminal psychiatric condition cannot be defined; (4) the proposed definition is not specific enough; and (5) considerations regarding mental capacity in the proposed criteria do not sufficiently account for the psycho-cognitive impairments in AN.
Our analysis responds to the critiques of our original proposed clinical characteristics of those with terminal AN. While refuting many of these critiques, we also appreciate the opportunity to refine our discussion of this complex topic and identify that there are multiple stages of SE-AN that can result in good clinical outcomes. Only when all of these have failed to provide adequate amelioration of suffering do a low number of patients progress to terminal AN.
By further refining our discussion of terminal AN, we aim to encourage eating disorders and palliative care specialists to develop expert consensus definitions for terminal AN and to generate authoritative clinical guidance for management of this population. By validating terminal AN as a distinct condition, patients with this subcategory of SE-AN, their families, and their caregivers facing end-of-life concerns may be better able to access palliative and hospice care and related services to help improve their overall experiences at this phase of life.
据估计,5%至20%的神经性厌食症(AN)患者会过早死亡。其中,一些重度且持续性神经性厌食症(SE-AN)患者会因营养不良的医学并发症或自杀而死亡。几乎没有文献就那些认识并接受自己无法战胜疾病的SE-AN患者的临床特征,为患者、临床医生及亲人提供指导。基于关于晚期疾病的一般医学文献,并结合作者在此生命阶段对患者的研究工作,我们之前描述了一小部分可能被视为患有终末期饮食失调症的SE-AN患者的四个临床特征。本文发表后,有几篇反对这些表述的观点文章发表。本文的目的是回应这些反对意见所提出的关键关切主题,扩展我们对这些患者及其家庭的姑息治疗及相关需求的讨论,并提出饮食失调和姑息治疗领域可如何为评估和管理这些患者制定更明确的标准和共识指南的方法。
基于对文献的选择性叙述性综述、我们对这些患者的综合经验以及临床推理,我们回应围绕五个主要主题分组的批评意见:即(1)诸如终末期AN之类的标签很危险;(2)由于AN是一种可治疗的疾病,不应将任何SE-AN患者视为终末期患者;(3)无法定义终末期精神疾病;(4)所提出的定义不够具体;(5)所提出标准中关于心理能力的考量未充分考虑AN中的心理认知损害。
我们的分析回应了对我们最初提出的终末期AN患者临床特征的批评。在反驳其中许多批评的同时,我们也感谢有机会完善对这个复杂主题的讨论,并认识到SE-AN有多个阶段,这些阶段都可能产生良好的临床结果。只有当所有这些都未能充分缓解痛苦时,才有少数患者会发展为终末期AN。
通过进一步完善我们对终末期AN的讨论,我们旨在鼓励饮食失调和姑息治疗专家为终末期AN制定专家共识定义,并为管理这一人群制定权威性的临床指南。通过将终末期AN确认为一种独特的病症,患有这种SE-AN亚类的患者、他们的家人以及面临临终问题的护理人员可能能够更好地获得姑息和临终关怀及相关服务,以帮助改善他们在生命这一阶段的总体体验。